Stocks
Sino Biopharmaceutical Limited (SBMFF) R&D/CAPEX US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| R&D/CAPEX, % | 138.3% | 141.3% | 197.8% | 254.0% | 258.4% | ||||
| Changes by years, y/y, % | +15pp | +3pp | +57pp | +56pp | +4pp | +15.9% | |||
Sino Biopharmaceutical Limited. R&D/CAPEX, %
Sino Biopharmaceutical Limited. R&D/CAPEX, changes, pp
Sino Biopharmaceutical Limited (SBMFF) R&D/CAPEX US GAAP (quarter values) |
|
| R&D/CAPEX, % | |
|---|---|
| Changes by years, y/y, % | |
| Changes by quarters, q/q, % | |
